Work

Adjuvant dose-dense doxorubicin plus cyclophosphamide followed by dose-dense nab-paclitaxel is safe in women with early-stage breast cancer: a pilot study

FWCI: 0.975
Cites: 13
Cited by: 25
Related to: 10